HMPL-453 in Advanced Malignant Mesothelioma

Clinical trial NCT04290325 · UNKNOWN

Trial details

NCT number: NCT04290325
Sponsor: Hutchison Medipharma Limited
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Mesothelioma

Start date: 2019-12-30
Primary completion: 2022-11-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.